MAY 1, 2018

CalciMedica Names Two Senior Executives to its Board of Directors

JANUARY 24, 2018

Research Collaboration between the San Francisco VA, UCSF and CalciMedica, Inc. to Present Results on CRAC Channel Inhibitors in a Stroke Model at International Conference

MAY 24, 2017

CalciMedica Receives Fast-Track Designation for CM4620, a Novel CRAC Channel Inhibitor to Treat Acute Pancreatitis

JANUARY 6, 2017

CalciMedica Initiates Phase 1 Clinical Studies for CRAC Channel Inhibitor

NOVEMBER 15, 2016

San Francisco VA, UCSF and CalciMedica, Inc. Present Results on CRAC Channel Inhibitors in Traumatic Brain Injury Model at Neuroscience Meeting

NOVEMBER 14, 2016

CalciMedica Announces Senior Clinical Development Hire

FEBRUARY 16, 2010

CalciMedica Announces Issuance of US Patent No. 7,645,588, a Composition Patent Involving STIM1, a Key Component of the CRAC Channel

DECEMBER 15, 2009

CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing

OCTOBER 13, 2009

CalciMedica Appoints Evelyn Graham to its Board of Directors

OCTOBER 13, 2008

CalciMedica Exercises Option to Acquire Additional Intellectual Property from TorreyPines Therapeutics

May 7, 2007

CalciMedica Acquires Exclusive Rights to Novel Immune Signaling Targets for Treating Autoimmune Diseases from the CBR Institute

MAY 7, 2007

TorreyPines Therapeutics Transfers Intellectual Property and Compounds for Treating Autoimmune Diseases to CalciMedica

GASTROENTEROLOGY 149: 481-492, 2015

Wen, L., Voronina, S., Javed, M.A., Awais, M., Szatmary, P., Latawiec, D., Chvanov, M., Collier, D., Huang, W., Barrett, J., Begg, M., Stauderman, K., Roos, J., Grigoryev, S., Ramos, S., Rogers, E., Whitten, J., Velicelebi, G., Dunn, M., Tepikin, A.V., Criddle, D.N., Sutton, R. Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models.

CELL CALCIUM 42: 133-144, 2007

Michael D. Cahalan, Shenyuan Zhang, Andy Yeromin, Kari Ohlsen, Jack Roos, and Kenneth A. Stauderman. Molecular basis of the CRAC channel. Cell Calcium 42: 133-144, 2007.

PNAS 103: 9357-9362, 2006

Zhang, S.L., Yeromin, A.V., Zhang, X.H.-F., Yu, Y., Safrina, O., Penna, A., Roos, J., Stauderman, K.A., and Cahalan, M.D. Genome-wide RNAi screen of Ca²⁺ influx identifies genes that regulate Ca²⁺ release-activated Ca²⁺ channel activity. PNAS 103: 9357-9362, 2006.

NATURE 437: 902-905, 2005

Zhang, S.L., Yu, Y., Roos, J., Kozak, J.A., Deerinck, T.J., Ellisman, M.H., Stauderman, K.A., and Cahalan, M.D. STIM1 is a Ca²⁺ sensor that activates CRAC channels and migrates from the Ca²⁺ store to the plasma membrane. Nature 437: 902-905, 2005.

J. CELL BIOLOGY 169: 435-445, 2005

Roos, J., DiGregorio, P.J., Yeromin, A.V., Ohlsen, K., Lioudyno, M., Zhang, S., Safrina, O., Wagner S., Cahalan, M.D., Velicelebi, G., and Stauderman, K.A. STIM1, an essential and conserved component of store-operated calcium channel function. J. Cell Biology 169: 435-445, 2005.

J. GEN. PHYSIOL. 123: 167-182, 2004

Yeromin, A.V., Roos, J., Stauderman, K.A., and Cahalan, M.D. A store-operated calcium channel in Drosophila S2 cells. J. Gen. Physiol. 123: 167-82, 2004.